NIH Study Uncovers New Mechanism of Action for Class of Chemotherapy Drugs
Published: Friday, November 02, 2012 Last Updated: Friday, November 02, 2012
National Institutes of Health (NIH) researchers have discovered a significant new mechanism of action for a class of chemotherapy drugs known as poly (ADP-ribose) polymerase inhibitors, or PARP inhibitors.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.